Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, June 2000, p. 1616-1623, Vol. 44, No. 6
Department of Microbiology and
Immunology1 and Department of
Medicine,2 Virginia Commonwealth University,
Medical College of Virginia Campus, Richmond, Virginia 23298-0049
Received 24 September 1999/Returned for modification 11 January
2000/Accepted 17 March 2000
The MICs for many oxacillin-resistant (OR) Staphylococcus
epidermidis (ORSE) strains are below the Staphylococcus
aureus methicillin or oxacillin resistance breakpoint. The
difficulty detecting the OR phenotype in S. epidermidis may
be due to extreme heterotypy in resistance expression and/or
transcriptional repression of mecA, the OR gene, by MecI.
To determine the role of these factors in the phenotypic expression of
ORSE, 17 geographically diverse mecI+ ORSE
isolates representing 14 distinct pulsed-field gel electrophoresis pulse types (>3 band differences) were investigated. Thirteen of the
14 types contained mecI and mecA
promoter-operator sequences known to be associated with maximal
mecA repression, and in all isolates, mecA
transcription was repressed. All 17 were heterotypic in their
resistance expression. Oxacillin MICs ranged from 1 to 128 µg/ml and
increased for 16 of 17 isolates after More than 70% of nosocomial
Staphylococcus epidermidis isolates are methicillin
resistant (MRSE) or oxacillin resistant (ORSE) (39), but
resistance is often difficult to detect by conventional susceptibility
testing methods. While Staphylococcus aureus clinical isolates tend to be either very susceptible or very resistant to
methicillin or oxacillin (MICs of <0.5 or >8 µg/ml, respectively), S. epidermidis strains are not as clearly bimodal in their
resistance pattern (21). The oxacillin MICs for many
S. epidermidis strains are 0.5 to 2 µg/ml, which is below
the breakpoint for oxacillin-resistant S. aureus (ORSA) (4 µg/ml), but these strains are found to contain mecA, the
gene that mediates oxacillin resistance. Resistance expression in these
S. epidermidis isolates can only be demonstrated when more
laborious susceptibility testing techniques are used. When the in vitro
expression of oxacillin resistance in S. epidermidis is
examined on agar plates containing increasing concentrations of a
As with S. aureus the production of an alternative,
It has been proposed (13) that among early ORSA strains,
repression of mecA transcription by mecI yielded
a In the following study, we have attempted to assess the relative
contributions of mecA transcriptional regulation and
heterotypic resistance expression to the low MICs seen for many
clinical ORSE isolates. We have chosen geographically diverse,
genetically unrelated ORSE isolates found in a previous study to
contain mecI by hybridization with a DNA probe. We have
examined the nucleotide sequence of mecI and mecA
P-O in these isolates, analyzed mecA transcription, and
assessed phenotypic expression in both broth and on agar in the
presence and absence of mecA regulation. Finally, we have assessed changes in the size of the OR subpopulation upon oxacillin exposure and the contribution of subpopulation selection to the MIC.
Bacterial strains and plasmids.
The S. epidermidis strains used in this study are listed in Table
1. Recombinant plasmids were generated
and maintained in Escherichia coli TB1 (38) or
JM109 (9) cells. The E. coli cloning vector used
was pUC19 (38). The E. coli-S. aureus shuttle vectors used were constructed by adding pE194ts (15, 33) to pUC19. The staphylococcal tetracycline and gentamicin resistance genes
used for selection of colonies containing recombinant vectors in
E. coli or S. aureus or S. epidermidis
were tetM (34) and aac/aph
(28), respectively.
0066-4804/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Phenotypic Expression of Oxacillin Resistance in
Staphylococcus epidermidis: Roles of mecA
Transcriptional Regulation and Resistant-Subpopulation
Selection
![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
-lactam induction. Allelic
replacement inactivation of mecI in three isolates
similarly resulted in a four- to sevenfold increase in MIC. In the two
of these three isolates producing
-lactamase, mecA
transcription was regulated by both mecI and
-lactamase
regulatory sequences. Heterotypic expression of resistance in these
three isolates was unaffected by either
-lactam induction or
mecI inactivation. However, prolonged incubation in
concentrations of oxacillin just sufficient to produce a lag in growth
(0.5 to 1.0 µg/ml) converted the population resistance expression
from heterotypic to homotypic. Homotypic conversion could also be
demonstrated in microtiter wells during MIC determinations in one
isolate for which the MIC was high. We conclude that the phenotypic
expression of S. epidermidis OR in broth can be affected
both by mecA transcriptional regulation and by
subpopulation resistance expression.
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
-lactam antibiotic, most isolates exhibit a heterotypic phenotype.
This type of resistance expression is defined by a small percentage of
cells (0.1%) that are able to survive on plates containing 100 µg of
oxacillin per ml; the surviving colonies are of different sizes. In
contrast, extreme heterotypic expression is relatively uncommon among
clinical S. aureus isolates; resistant subpopulations
comprise a greater proportion of the overall population than among
S. epidermidis strains, and often every member of the population is highly resistant (homotypic or homogeneous
resistance) (T. M. Dickinson and G. L. Archer,
unpublished data).
-lactam-resistant penicillin-binding protein, PBP2a, encoded by
mecA, confers OR in S. epidermidis (2,
4). In addition, a two-gene operon, mecR1-mecI, that
encodes a signal transducer/inducer and repressor, respectively, is
divergently transcribed from mecA (14, 35). MecI
represses mecA and autorepresses mecR1-mecI transcription by binding to promoter-operator (P-O) sequences (32). The gene products of the mecA regulatory
system have amino acid similarity to BlaR1 and BlaI, proteins that
regulate transcription of the
-lactamase gene, blaZ.
Previous studies have shown that the mec and bla
regulatory systems are able to interact and that BlaI can regulate
mecA transcription (10, 29, 37). Sequences hybridizing with mecR1-mecI probes are present in one-half
to two-thirds of ORSA and ORSE clinical isolates (2), while
the
-lactamase gene is found in 90% of clinical isolates
(20).
-lactam-susceptible phenotype, because repression led to little or
no production of PBP2a, and mecA transcription was poorly
inducible through MecR1. According to this hypothesis, the evolution of
clinically resistant ORSA required mutations in either mecI
or the mecA P-O. Additional chromosomal mutations were
necessary to convert heterotypic resistance expression to homotypic
(13). However, a recent analysis of clinical ORSE isolates
from one hospital in Japan found that all contained mecI and
mecA P-O sequences identical to those associated with
maximal mecA repression in ORSA (17).
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
TABLE 1.
Properties of the S. epidermidis strains used
in this study
Materials and media.
Mueller-Hinton broth (MHB) and agar
(MHA) (BBL Microbiology Systems, Cockeysville, Md.) and brain heart
infusion (BHI) broth and agar (Difco Laboratories, Detroit, Mich.),
with and without selective additives (Sigma, St. Louis, Mo.; United
States Biochemicals, Cleveland, Ohio), were used for the subculture and
maintenance of E. coli, S. epidermidis, and
S. aureus strains. The antibiotics and concentrations used
for E. coli strains for initial selection after
transformation were as follows: ampicillin, 50 µg/ml; gentamicin, 5 µg/ml; minocycline, 1 µg/ml; and tetracycline, 5 µg/ml. The antibiotics used for S. aureus and S. epidermidis
strains for determining antibiotic resistance and initial selection
after electroporation or conjugative mobilization were gentamicin (5 µg/ml), chloramphenicol (10 µg/ml), erythromycin (10 µg/ml),
tetracycline (5 µg/ml), minocycline (1 µg/ml), and mupirocin (20 µg/ml). The antibiotics used to select for the recipient S. epidermidis in conjugative mobilization were novobiocin (1 µg/ml) and rifampin (10 µg/ml). Induction experiments were
performed with 2-(2'-carboxyphenol) benzoyl-6-amino penicilloic acid
(CBAP) (5 µg/ml) and oxacillin (0.1, 0.3, 0.5, 0.6, or 1 µg/ml) in
broth. Other selective additives, such as sodium citrate (Sigma) (8 mM,
for transductions) or
-D-galactopyranoside (X-Gal) (50 µg/ml; Inalco Spa, Milano, Italy), were added to the media as required.
-Lactamase production.
-Lactamase activity was
detected by growing single colonies of bacteria for 16 h on BHI
agar supplemented with 1% (wt/vol) soluble starch. Five milliliters of
a 0.1 N I2 solution in 0.4 M KI containing 20 mg of
benzylpenicillin per ml was pipetted over the colonies and allowed to
sit for 10 s before the excess was poured away. The presence of a
rapidly spreading white halo around the colonies, as the penicilloic
acid reacted with the iodine and decolorized the agar around the
colony, indicated the presence of
-lactamase in the bacteria.
-lactamase activity to assess induction by
-lactam antibiotics was accomplished by using colorimetric detection
of nitrocefin hydrolysis. Bacteria were grown in BHI at 37°C to an
optical density at 600 nm (OD600) of 0.6 with (induced) and
without (uninduced) CBAP (5 µg/ml). Bacteria were harvested, pelleted, and resuspended in 2 ml of Z buffer (0.06 M
Na2HPO4, 0.04 M
NaH2PO4, 0.01 M KCl, 0.001 M MgSO4,
0.05 M
-mercaptoethanol, pH 7.0). One milliliter of the cell
suspension and 2.5 g of 0.1-mm-diameter Zirconia beads (Biospec
Products, Bartlesville, Okla.) were added to a 2-ml screw-cap tube. The
samples were bead beaten (Biospec Products) for 5 min at 4°C and
centrifuged for 10 min at 26,895 × g at 4°C. One
hundred microliters of the supernatant was removed and added to 750 µl of 0.1 M sodium phosphate buffer (pH 7.0) in a visible cuvette.
One hundred-fifty microliters of a 0.2-mg/ml concentration of
nitrocefin (kindly provided by Bristol-Meyers Squibb) was added to the
cuvette, and the sample was mixed and read at an OD490 at
30 min.
Cloning, transformation, and DNA manipulation.
All
restriction endonuclease digestions and ligation reactions were
performed per the manufacturer's (New England Biolabs, Beverly, Mass.)
specifications. Plasmids were electroporated (31; T. B. Luchansky, P. M. Muriana, and T. R. Klaenhammer,
Bio-Rad technical bulletin no. 1350, p. 1-3. Bio-Rad Laboratories,
Richmond, Calif.) into E. coli in the Bio-Rad Gene Pulser.
Shuttle plasmids were moved from E. coli to S. aureus by electroporation into the restriction-deficient S. aureus strain RN4220 (18) as previously described
(22). Plasmids were introduced into other S. aureus strains by transduction with the general transduction phage
80
(16, 26). Transductions using phage 80
and the
isolation of both E. coli and staphylococcal plasmid and
genomic DNA were performed as previously described (16, 25,
26).
Conjugative mobilization. Conjugative mobilization was used to introduce plasmid DNA from S. aureus into S. epidermidis and was performed by using a three-plasmid S. aureus donor strain as previously described (36). The recipient S. epidermidis strains were made novobiocin (1 µg/ml) and rifampin (10 µg/ml) resistant by serial passage on selective agar plates. The donor S. aureus strain, RN4220, contained the plasmids pGO626, pC221, and pGO400. To produce the tetracycline- and minocycline-resistant plasmid pGO626 (13.8 kb), a 700-bp nick site from pC221 (27) was added to pGO514. pGO514 is the plasmid containing tetM-inactivated mecI and a temperature-sensitive pE194 origin of replication described previously for allelic replacement of mecI in S. aureus (25). pC221 (4.6 kb) encodes chloramphenicol resistance and provides mobilization genes that act in trans on the nick site of pGO626 (27, 36). pGO400 (33.8 kb), a member of the pGO1 family of conjugative plasmids, encodes resistance to mupirocin and provides the conjugative apparatus (23). Following filter mating (23), colonies were sought that were resistant to novobiocin, rifampin, and minocycline, indicating mobilization of pGO626 into S. epidermidis, and susceptible to chloramphenicol and mupirocin, identifying those colonies that did not receive pC221 and pGO400 by cotransfer. Differentiation of S. epidermidis recipients from S. aureus donors was also achieved by performing matings on plates containing mannitol, resulting in white S. epidermidis and yellow S. aureus colonies.
Plasmid curing and allelic replacement. S. epidermidis isolates harboring plasmid constructs with the pE194ts replicon (pGO626) were cured of their plasmids in order to detect allelic replacement of chromosomal genes by homologous recombination (25). Briefly, single colonies were inoculated into 10 ml of BHI broth and grown for 16 h at 30°C with antibiotic selection. Following growth of S. epidermidis at the nonpermissive temperature for plasmid replication (43°C), colonies were patched to minocycline, gentamicin, and erythromycin plates. Colonies were sought that were minocycline resistant, indicating chromosomal integration into the replacement locus, and either gentamicin or erythromycin susceptible, indicating secondary recombination to remove plasmid DNA. The inclusion of erythromycin and gentamicin resistance genes in the pGO626 plasmid allowed us to include in this study S. epidermidis strains that were resistant to either erythromycin or gentamicin, but not both. However, all isolates used had to be minocycline susceptible, so that chromosomal insertion of the tetM marker could be identified.
EOP. Phenotypic expression of OR was determined by the efficiency of plating (EOP) procedure described by Hackbarth et al. (11), except that oxacillin was used instead of methicillin or nafcillin. Staphylococcal strains were inoculated into 5 ml of BHI broth and incubated for 16 h at 37°C with constant shaking. Cultures were then serially diluted and plated on MHA containing 0, 10, 20, 50, 100, 250, 500, and 800 µg of oxacillin per ml. The plates were incubated at 30°C for 96 h, after which CFU were counted and expressed as a ratio of cells growing in plates containing oxacillin to the number of cells on antibiotic-free medium. We defined heterotypic resistance as a population decrease of at least 2 log10 on 20-µg/ml oxacillin plates and of at least 3 log10 on 100-µg/ml oxacillin plates.
Southern blot analysis. Alkaline capillary transfer, fixation of DNA to positively charged Zeta-Probe nylon membrane (Bio-Rad, Hercules, Calif.), and hybridization were performed per the directions of the manufacturer (Bio-Rad, Hercules, Calif.) and as previously described (1).
Northern blot and PBP analysis. Cellular RNA isolation, formaldehyde gel separation, 20× SSC (1× SSC is 0.15 M NaCl plus 0.015 M sodium citrate) capillary transfer, fixation of RNA to neutrally charged nylon membrane (Qiagen, Valencia, Calif.), and hybridization were performed according to established protocols (25). PBPs were analyzed by Michael Pucci at the Bristol-Myers Squibb Pharmaceutical Research Institute by methods previously described (25). Transcript and protein abundance on gels were quantified by scanning densitometry with an AlphaImager 1000 digital imaging system (Alpha Innotech Corp., San Leandro, Calif.).
PCR amplification. PCR amplification of DNA sequences was performed to generate fragments for cloning into pGO626 and to create the mecA probe for Northern blot analysis. The primer sequences and amplification protocols were performed as previously described (25).
Sequence analysis. DNA sequence analysis was performed to confirm the sequence of mecI and the mecA-mecR1 or -mecI P-O in the different S. epidermidis isolates. Sequencing was performed by the automated laser fluorescence technique employing fluorescein-labeled oligonucleotides (Applied Biosystems and the Virginia Commonwealth University Nucleic Acid Synthesis and Analysis Core Facility).
PFGE. Genomic DNA was prepared and cut with the restriction enzyme SmaI for pulsed-field gel electrophoresis (PFGE) by established methods (8). The following parameters (22 h at 14°C) were used to visualize large fragments of DNA: 6 V/cm; initial pulse time, 1 s; final pulse time, 30 s.
Susceptibility testing. MICs for S. epidermidis isolates were determined in cation-supplemented MHB containing 2% NaCl by using a 105-CFU/ml inoculum, according to National Committee for Clinical Laboratory Standards (NCCLS) guidelines (24). MIC determinations were performed in quadruplicate and read after an 18- to 24-h incubation at 37°C. The only exception to the NCCLS guidelines was incubation of the MIC plates at 37°C; the guidelines stipulate an incubation temperature of 35°C.
| |
RESULTS |
|---|
|
|
|---|
Characterization of clinical S. epidermidis.
We
chose to study 22 geographically and chronologically diverse clinical
ORSE isolates previously shown to contain the mecR1-mecI regulatory region by DNA hybridization. This collection of
multiresistant S. epidermidis isolates came from five areas
of North America (Richmond, Boston, Toronto, Birmingham, and Portland)
collected over 19 years (1970 to 1989). Southern blot analysis of
genomic DNA digested with the restriction endonuclease BamHI
was probed with a mecR1-mecI DNA probe to confirm the
presence of the regulatory region in each of the isolates. Pulsed-field
gel (contour-clamped homogeneous electric field [CHEF]) analysis of
S. epidermidis genomic DNA digested with SmaI was
performed and identified 17 unique banding patterns (at least 2 band
differences) representing 14 pulse types (>3 band differences) listed
in Table 1. The S. epidermidis isolates were then screened
for antibiotic resistance to gentamicin, tetracycline, minocycline,
chloramphenicol, erythromycin, and oxacillin. All isolates were
resistant to oxacillin, and most of the isolates were resistant to two
or three of the additional antibiotics tested (Table 1). All but one
isolate (SE42) produced
-lactamase.
Oxacillin MICs.
Broth microdilution oxacillin MICs were
determined for all 17 S. epidermidis isolates (Table 1). The
range of MICs obtained was consistent with the findings of others for
S. epidermidis clinical isolates containing the OR gene
mecA (21). For five isolates (29%), the MIC was
2 µg/ml; for three isolates (18%), the MIC was 4 µg/ml (the
NCCLS oxacillin resistance breakpoint for S. aureus); and
for the remaining nine isolates (53%), the MIC was
8 µg/ml.
EOP.
EOPs examined to determine the OR phenotypes of the
17 clinical S. epidermidis isolates revealed that each had a
heterotypic phenotype (Table 1). All isolates had at least a
2-log10 drop in colony counts on plates containing
20
µg of oxacillin per ml, and all but one isolate (SE55) had at least a
3-log10 drop in colony count on plates containing
100
µg of oxacillin per ml. The reduction in colony count on plates
containing 10 µg of oxacillin per ml was more variable.
Analysis of mecI and mecR1.
PCR
amplification and subsequent nucleotide sequencing of the
mecI gene and the mecA-mecR1 P-O revealed that 13 of the 14 S. epidermidis pulse types were identical to the
wild-type S. aureus mecI and P-O sequences associated with
maximal mecA transcriptional repression (S. aureus strain N315 [14]). The lone mutation
observed was a single A-to-T point mutation in the mecI of
pulse type IX, resulting in an amino acid change
(isoleucine
asparagine) at position 66.
-lactam antibiotic, CBAP (5 µg/ml), all but 1 (SE34) of the 17 mecI-positive S. epidermidis isolates produced
mecA transcript equivalent to that of an unregulated isolate
(~50-fold increase). mecA transcript in SE34 induced with
5 µg of CBAP per ml increased ~10-fold over uninduced SE34
mecA transcript. These data indicate that in the S. epidermidis clinical isolates, mecI and
mecR1 are largely intact and functional. MecI represses
mecA transcription and consequently PBP2a production, while
MecR1 provides the signal sensor/transducer necessary to relieve MecI
repression following induction with
-lactams.
|
mecI allelic replacement mutagenesis. mecI allelic replacement mutagenesis was performed with three mecI+ S. epidermidis isolates (SE20, SE42, and SE53) to observe the relationship of mecA transcriptional repression to the OR phenotype. Deletion of mecI was confirmed by Southern blot hybridization by noting the loss of a 0.7-kb BglII fragment from deletion mutants.
Northern blot analysis of mecA transcript in the mecI mutant S. epidermidis isolates showed an increase in mecA transcript compared to the level of mecA transcript in mecI+ parents. The SE42 mecI knockout resulted in an ~50-fold increase in mecA transcription, as determined by scanning densitometry (Fig. 2A). The PBP profile of SE42 and SE42
mecI also showed a comparable increase in PBP2a after
the deletion of mecI (Fig. 1), correlating with the Northern
blot data. SE42 produces no
-lactamase and contains no
blaZ regulatory sequences. However, in the two S. epidermidis isolates (SE20 and SE53) that produced
-lactamase,
there was only a three- to sixfold increase in mecA transcription after mecI inactivation (Fig. 2B and C),
presumably due to the presence of the blaZ repressor BlaI,
which has also been shown to repress mecA transcription.
Both SE20 and SE53 were shown to contain blaI sequences by
Southern blot hybridization. Maximal mecA transcription in
SE20
mecI and SE53
mecI was achieved by
induction with CBAP (Fig. 2B and C).
|
-lactamase assay was performed to determine if the
-lactamase repressor BlaI was functional in isolates
SE20
mecI and SE53
mecI. The mecI
mutant isolates known to contain a
-lactamase plasmid were induced
for 3 h with and without 5 µg of CBAP per ml.
-Lactamase was
barely detectable in the negative control (SE42
mecI,
OD600 of 0.042) and the
-lactamase-positive isolates (SE20
mecI, OD600 of 0.085;
SE53
mecI, OD600 of 0.08) in the absence of
inducer. In the presence of inducer, the
-lactamase-positive isolates (SE20
mecI, OD600 of 0.65;
SE53
mecI, OD600 of 0.86) produced 8- and
11-fold more
-lactamase, respectively, while the negative control
(SE42
mecI, OD600 of 0.043) showed no increase in activity. Thus, the
-lactamase repressor BlaI was functional in
these isolates until inducer was added to the media.
Induction of mecA transcription.
SE42
mecA transcription was induced by growing the isolate in
various concentrations of oxacillin (0.1, 0.3, and 0.5 µg/ml) to an
OD600 of 0.6. A progressive increase in mecA
transcription, as determined by scanning densitometry measurement of
transcripts on Northern blots, was seen as the amount of oxacillin in
the medium increased (Table 2). SE42
mecA transcript was repressed in the absence of inducer and
was 86% of the maximum seen in SE42
mecI when grown with
0.5 µg of oxacillin per ml, while 0.1 and 0.3 µg of oxacillin per
ml provided relatively less induction (17 and 65% of maximal,
respectively). Those strains inducibly producing
-lactamase (SE20
and SE53) displayed a stepwise pattern of mecA induction
similar to that of SE42 at the same concentrations of oxacillin and
CBAP. However, in SE20
mecI and SE53
mecI
with only partially repressed mecA transcription, presumably
due to the presence of the
-lactamase regulators, maximal induction
was achieved with only 0.1 µg of oxacillin per ml. The data suggest that transcription of mecA is induced approximately fivefold
more easily through bla than through mec
regulatory sequences.
|
MICs and EOPs of induced isolates.
Oxacillin MICs (Table 1)
for the mecI mutant strains increased in each of the
isolates from either 8 µg/ml (SE20 and SE42) or 1 µg/ml (SE53) to
128 µg/ml (SE20
mecI, SE42
mecI, and
SE53
mecI). However, all three of the mecI
knockout strains still had heterotypic EOP phenotypes that were within
1 log10 of the parent at all oxacillin concentrations (Fig.
3).
|
Oxacillin growth curves.
The effect of
mecI-mediated mecA repression on the growth of
S. epidermidis exposed to
-lactam antibiotics in broth
was next sought. SE42 and SE42
mecI were both grown for
6 h at 37°C in the presence and absence of 0.6 µg of oxacillin
per ml in BHI broth. Growth of the bacteria was monitored at
OD600. In the presence of oxacillin, SE42
mecI+ displayed a considerable lag in early
growth, with an OD600 at 6 h of 0.026 (Fig.
4). In contrast, the OD600 of
SE42
mecI at 6 h in the presence and absence of
oxacillin was similar to that seen for SE42 in the absence of
antibiotics. Results similar to those described above for SE42 were
seen when SE20 and SE53 and their mecI-deleted derivatives
were grown in the presence of oxacillin.
|
Heterotypic-to-homotypic conversion in the presence of oxacillin. When sufficient oxacillin was added to S. epidermidis to cause a lag in growth, the EOP phenotype increased between 3 and 5 log10, changing the isolates from a heterotypic to a more homotypic resistance expression (Fig. 3). Incubation of S. epidermidis in concentrations of oxacillin or CBAP that caused no growth lag produced no change in the EOP phenotype despite maximal induction of mecA transcription.
The presence or absence of mecI regulation of mecA transcription influenced the concentration of oxacillin required to produce a growth lag. For all three mecI+ strains, growth inhibition and conversion from heterotypic to homotypic EOP expression could be achieved by incubation in 0.5 µg of oxacillin per ml. However, for each mecI mutant derivative, growth inhibition was only achieved by incubation in 1.0 µg of the antibiotic per ml.Relationship between MIC and the size of the resistant
population.
Oxacillin MICs were determined for isolates SE42,
SE20, and SE53 before and after converting expression from heterotypic
to homotypic growth. In all cases, the MICs for isolates exhibiting homotypic resistance expression were 128 or 256 µg/ml. In addition, two isolates, SE33 and SE65, that exhibited extremely heterotypic resistance expression, yet for which the MICs were high (64 and 128 µg/ml, respectively [Table 1]), were examined following oxacillin MIC determination. Bacteria were removed from microtiter wells containing 1, 4, 16, and 32 (SE33) or 64 (SE65) µg of oxacillin per
ml following overnight incubation, and EOP experiments were performed.
SE33 from the MIC microtiter wells became progressively more homotypic
in resistance expression with increasing concentrations of oxacillin.
In contrast, colonies from wells of SE65 showed no change in the
heterotypic subpopulation profile, even at oxacillin concentrations as
high as 64 µg/ml (Fig. 5). Colonies
taken from 1-µg/ml-oxacillin wells of two isolates for which MICs
were low (SE53 and SE60) exhibited no change in EOP.
|
| |
DISCUSSION |
|---|
|
|
|---|
The ORSE isolates chosen for this study were previously shown to
contain DNA sequences that hybridized with a probe containing the
mecA transcriptional repressor, mecI
(2). In that study, 48% of the clinical isolates chosen
hybridized with the mecI probe; in the other isolates,
mecI was deleted and replaced by an IS element
(IS1272). In the present study, we have shown that all 17 unique ORSE pulse types with mecI-hybridizing sequences had intact and functional mecA regulators: mecI and
mecA P-O DNA sequences in 16 of 17 were the same as
wild-type, functional ORSA sequences; baseline, uninduced
mecA transcription was heavily repressed; transcription
could be induced by
-lactam compounds; and inactivation of
mecI led to an increase in both mecA
transcription and MICs. The presence of intact mecA
regulators in ORSE, in contrast to mutation of these regulators in
ORSA, has been previously reported for a group of isolates from a
single Japanese hospital (17). The role of these regulators
in determining the phenotypic expression of
-lactam resistance in
ORSE had not, however, been examined.
The relevance of assessing the relationship of mecA
transcriptional repression to phenotype in ORSE is based on several
differences between
-lactam resistance in ORSE and that in ORSA.
First, as noted above, those ORSE isolates that have mecA
regulators contain intact and functional genes in contrast to the usual
presence of mutations and insertions that inactivate these genes in
ORSA. Second, the oxacillin MICs for as many as 30% of clinical,
mecA-positive S. epidermidis isolates, as
determined by broth microdilution, are
2 µg/ml, below the NCCLS
breakpoint that identifies more than 95% of mecA-positive
S. aureus strains (21). Finally, the majority of
ORSE strains exhibit extreme heterotypy when examined by EOP on
oxacillin-containing agar; this expression class is less common among
clinical ORSA isolates (T. M. Dickinson and G. L. Archer,
unpublished data).
This study documented a direct relationship between resistance to
oxacillin and mecA transcription when S. epidermidis was grown in broth. This relationship was best shown
when low concentrations of the antibiotic (0.5 to 1.0 µg/ml) were
used during rapid growth in broth over 6 h, but was also seen at
higher antibiotic concentrations during low inoculum overnight broth
MIC determinations. These data imply that, under conditions of rapid
bacterial growth in broth, the presence of increasing amounts of PBP2a
in membranes provides increasing resistance to
-lactam antibiotics.
However, our data also showed that exposure of bacteria in broth to
concentrations of oxacillin that suppressed growth selected a highly
oxacillin-resistant subpopulation. This selection of a more highly
-lactam-resistant population upon
-lactam exposure has also been
noted for mecA-positive S. aureus (6,
12) and has been attributed to changes in the bacterial cell wall
that improve the efficiency of PBP2a in cell wall construction. The
nature of the conversion of heterotypic to homotypic resistance
expression among staphylococci has eluded molecular definition for some
time. Data remain, therefore, largely descriptive. However, preliminary
studies suggest that growth in
-lactam antibiotics selects a mutant
population rather than inducing a regulatory pathway (J. E. Finan,
T. M. Dickinson, A. E. Rosato, and G. L. Archer,
unpublished data).
The selection of the resistant subpopulation was related to mecA transcription only in that strains with repressed transcription required lower concentrations of oxacillin to select high-level resistance than did strains with unregulated mecA transcription. The size of the highly resistant subpopulation (heterotypic expression), as determined by EOP, was unrelated to mecA transcription and thus to PBP2a quantity. The lack of correlation between heterotypic resistance expression and mecA transcription or PBP2a quantity has been noted by other investigators studying S. aureus (5, 25).
These observations suggest that there are at least two mechanisms that
determine the survival of mecA-positive S. epidermidis strains following their exposure to
penicillinase-resistant penicillins. Upon initial exposure to a
-lactam antibiotic, the growth rate of the planktonic cells that
constitute the majority of the bacterial population may be directly
related to their expression of PBP2a. The expression of PBP2a,
regulated at the level of mecA transcription, is affected by
both the MecR1-MecI and BlaR1-BlaI sensor-transducers and repressors.
In contrast, selection of the more highly resistant minority
subpopulation occurs more slowly, is likely to require the
participation of additional chromosomal factors (3, 7, 30),
and may be favored by growth on solid surfaces or in biofilms.
The contribution of
-lactamase regulators to mecA
transcriptional regulation was also observed in this study. When
mecI was inactivated in isolates SE20 and SE53,
blaI regulation persisted, affording partial transcriptional
repression. However, blaI repression was easily and rapidly
removed following induction with concentrations of
-lactam
antibiotics that were one-fifth those required for induction of
mecA transcription through mecR1 and
mecI. The difference in
-lactam induction of
mecA through mecR1 (slow and partial) versus that
through blaR1 (rapid and complete) has been noted previously
(19, 29) in S. epidermidis and S. aureus. The inefficiency of mecA induction through
mecR1 by oxacillin may further explain why isolates
containing these regulators have persistent phenotypic repression
following relatively short incubation times in broth. In contrast, in
ORSE isolates without mecI, most of which will contain
-lactamase regulatory sequences, mecA transcription is rapidly induced following
-lactam exposure, and, therefore,
-lactamase regulators contribute very little to
mecA-related variations in phenotypic expression.
Our data showed that the ORSE oxacillin MIC, as determined in broth
with the low standard inoculum, could be independently affected both by
mecA transcriptional regulation and by a change in the size
of the resistant subpopulation. Inactivation of mecI and
induction of mecA transcription by CBAP were able to raise the MIC without increasing the size of the highly resistant
subpopulation, as determined by EOP. However, since the MICs for only 8 of the 17 unique mecI-positive ORSE pulse types that we
examined were
4 µg/ml and the MICs for some isolates with naturally
occurring mecI deletions are low (T. M. Dickinson and
G. L. Archer, unpublished data), transcriptional repression of
mecA is not a complete explanation for low broth dilution MICs.
We also showed that even though there was no correlation between the
initial size of the resistant subpopulation (baseline EOPs) and MICs,
when isolates for which MICs were low were converted from heterotypic
to homotypic resistance expression, MICs increased markedly. In
addition, colonies removed from microtiter wells of one ORSE isolate
for which the MIC was high and with a very heterotypic baseline EOP
became progressively more homotypic in resistance expression as the
oxacillin concentrations in the wells increased. This suggests that,
with the low standard inoculum used for MIC testing, the ability of
some isolates to increase the size of their highly resistant
subpopulations upon
-lactam exposure can determine the MICs for
them. It further suggests that the differences in MICs for some ORSE
isolates may be due to genetically determined variations in their
capacity to convert from heterotypic to homotypic resistance expression
upon
-lactam exposure. However, the failure of SE65 to exhibit
homotypic conversion in microtiter MIC wells containing high
concentrations of oxacillin suggests that there are mechanisms that
determine ORSE broth microtiter MICs other than those examined in this
study. Furthermore, since the MIC measures rapid growth in broth and
the EOP determines subpopulation distribution on agar, the two assays
may be measuring different aspects of the response of some S. epidermidis isolates to
-lactam antibiotics.
| |
ACKNOWLEDGMENT |
|---|
This work was supported in part by USPHS grant R37 AI35705 from the National Institute of Allergy and Infectious Diseases.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Division of Infectious Diseases, Department of Medicine, Virginia Commonwealth University, Medical College of Virginia, Box 980049, Richmond, VA 23298-0049. Phone: (804) 828-9711. Fax: (804) 828-3097. E-mail: garcher{at}gems.vcu.edu.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Archer, G. L., J. A. Thanassi, D. M. Niemeyer, and M. J. Pucci. 1996. Characterization of IS1272, an insertion sequence-like element from Staphylococcus haemolyticus. Antimicrob. Agents Chemother. 40:924-929[Abstract]. |
| 2. |
Archer, G. L.,
D. M. Niemeyer,
J. A. Thanassi, and M. J. Pucci.
1994.
Dissemination among staphylococci of DNA sequences associated with methicillin resistance.
Antimicrob. Agents Chemother.
38:447-454 |
| 3. | Berger-Bachi, B., and M. Tschierske. 1998. Role of Fem factors in methicillin resistance. Drug Resistance Updates 1:325-335[CrossRef][Medline]. |
| 4. |
Chambers, H. F.
1987.
Coagulase-negative staphylococci resistant to -lactam antibiotics in vivo produced penicillin-binding protein 2a.
Antimicrob. Agents Chemother.
31:1919-1924 |
| 5. | Chambers, H. F. 1997. Methicillin resistance in staphylococci: molecular and biochemical basis and clinical implications. Clin. Microbiol. Rev. 10:781-791[Abstract]. |
| 6. |
Chambers, H. F., and C. J. Hackbarth.
1987.
Effect of NaCl and nafcillin on penicillin-binding protein 2a and heterogeneous expression of methicillin resistance in Staphylococcus aureus.
Antimicrob. Agents Chemother.
31:1982-1988 |
| 7. |
de Lencastre, H., and A. Tomasz.
1994.
Reassessment of the number of auxiliary genes essential for expression of high-level methicillin resistance in Staphylococcus aureus.
Antimicrob. Agents Chemother.
38:2590-2598 |
| 8. |
Fey, P. D.,
M. W. Climo, and G. L. Archer.
1998.
Determination of the chromosomal relationship between mecA and gyrA in methicillin-resistant coagulase-negative staphylococci.
Antimicrob. Agents Chemother.
42:306-312 |
| 9. | Grough, J., and N. Murray. 1983. Sequence diversity among related genes for recognition of specific targets in DNA molecules. J. Mol. Biol. 166:1-19[CrossRef][Medline]. |
| 10. |
Hackbarth, C. J., and H. F. Chambers.
1993.
blaI and blaR1 regulate -lactamase and PBP 2a production in methicillin-resistant Staphylococcus aureus.
Antimicrob. Agents Chemother.
37:1144-1149 |
| 11. |
Hackbarth, C. J.,
C. Miick, and H. F. Chambers.
1994.
Altered production of penicillin-binding protein 2a can affect phenotypic expression of methicillin resistance in Staphylococcus aureus.
Antimicrob. Agents Chemother.
38:2568-2571 |
| 12. |
Hartman, B. J., and A. Tomasz.
1986.
Expression of methicillin resistance in heterogeneous strains of Staphylococcus aureus.
Antimicrob. Agents Chemother.
29:85-92 |
| 13. | Hiramatsu, K. 1995. Molecular evolution of MRSA. Microbiol. Immunol. 39:531-543[Medline]. |
| 14. | Hiramatsu, K., K. Asada, E. Suzuki, K. Okonogi, and T. Yokota. 1992. Molecular cloning and nucleotide sequence determination of the regulator region of mecA gene in methicillin-resistant Staphylococcus aureus (MRSA). FEBS Lett. 298:133-136[CrossRef][Medline]. |
| 15. |
Horinouchi, S., and B. Weisblum.
1982.
Nucleotide sequence and functional map of pE194, a plasmid that specifies inducible resistance to macrolide, lincosamide, and streptogramin type B antibiotics.
J. Bacteriol.
150:804-814 |
| 16. | Kasatiya, S. S., and J. Baldwin. 1967. Nature and the determination of tetracycline resistance in Staphylococcus aureus. Can. J. Microbiol. 13:1079-1086[Medline]. |
| 17. |
Kobayashi, N.,
K. Taniguchi, and S. Urasawa.
1998.
Analysis of diversity of mutations in the mecI gene and mecA promoter/operator region of methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis.
Antimicrob. Agents Chemother.
42:717-720 |
| 18. | Kreiswirth, B. N., A. Lofdahl, M. J. Betley, M. O'Reilly, P. M. Schlievert, M. S. Bergdoll, and R. P. Novick. 1983. The toxic shock exotoxin structural gene is not detectably transmitted by a phage. Nature 305:709-712[CrossRef][Medline]. |
| 19. | Kuwahara-Arai, K., N. Kondo, S. Hori, E. Tateda-Suzuki, and K. Hiramatsu. 1996. Suppression of methicillin resistance in a mecA-containing pre-methicillin-resistant Staphylococcus aureus strain is caused by the mecI-mediated repression of PBP2' production. Antimicrob. Agents Chemother. 40:2680-2685[Abstract]. |
| 20. | Maranan, M. C., B. Moreira, S. Boyle-Vavra, and R. S. Daum. 1997. Antimicrobial resistance in staphylococci. Infect. Dis. Clin. N. Am. 11:813-849[CrossRef][Medline]. |
| 21. | McDonald, C. L., W. E. Maher, and R. J. Fass. 1995. Revised interpretation of oxacillin MICs for Staphylococcus epidermidis based on mecA detection. Antimicrob. Agents Chemother. 39:982-984[Abstract]. |
| 22. |
Morton, T. M.,
D. M. Eaton,
J. L. Johnson, and G. L. Archer.
1993.
DNA sequences and units of transcription of the conjugative transfer gene complex (trs) of Staphylococcus aureus plasmid pGO1.
J. Bacteriol.
175:4436-4447 |
| 23. | Morton, T. M., J. L. Johnson, J. Patterson, and G. L. Archer. 1995. Characterization of a conjugative staphylococcal mupirocin resistance plasmid. Antimicrob. Agents Chemother. 39:1272-1280[Abstract]. |
| 24. | National Committee for Clinical Laboratory Standards. 1993. Approved standard M7-A3. Dilution antimicrobial susceptibility tests for bacteria that grow aerobically. National Committee for Clinical Laboratory Standards, Villanova, Pa. |
| 25. |
Niemeyer, D. M.,
M. J. Pucci,
J. A. Thanassi,
V. K. Sharma, and G. L. Archer.
1996.
Role of mecA transcriptional regulation in the phenotypic expression of methicillin resistance in Staphylococcus aureus.
J. Bacteriol.
178:5464-5471 |
| 26. | Novick, R. 1967. Properties of high frequency transducing phage in Staphylococcus aureus. Virology 33:155-166[CrossRef][Medline]. |
| 27. |
Projan, S. J., and G. L. Archer.
1989.
Mobilization of the relaxable Staphylococcus aureus plasmid pC221 by the conjugative plasmid pGO1 involves three pC221 loci.
J. Bacteriol.
171:1841-1845 |
| 28. | Rouch, D. A., M. E. Byrne, Y. C. Kong, and R. A. Skurry. 1987. The aacA-aphD gentamicin and kanamycin resistance determinant of Tn-4001 from Staphylococcus aureus: expression and nucleotide sequence analysis. J. Gen. Microbiol. 133:3039-3052[Medline]. |
| 29. |
Ryffel, C.,
F. H. Kayser, and B. Berger-Bächi.
1992.
Correlation between regulation of mecA transcription and expression of methicillin resistance in staphylococci.
Antimicrob. Agents Chemother.
36:25-31 |
| 30. |
Ryffel, C.,
A. Strässle,
F. Kayser, and B.-B. Bächi.
1994.
Mechanisms of heteroresistance in methicillin-resistant Staphylococcus aureus.
Antimicrob. Agents Chemother.
38:724-728 |
| 31. | Schenk, S., and R. A. Laddaga. 1992. Improved method for electroporation of Staphylococcus aureus. FEBS Microbiol. Lett. 94:1333-1338. |
| 32. |
Sharma, V. K.,
C. J. Hackbarth,
T. M. Dickinson, and G. L. Archer.
1998.
Interaction of native and mutant MecI repressors with sequences that regulate mecA, the gene encoding penicillin binding protein 2a in methicillin-resistant staphylococci.
J. Bacteriol.
180:2160-2166 |
| 33. |
Sharma, V. K.,
J. L. Johnston,
T. M. Morton, and G. L. Archer.
1994.
Transcriptional regulation by TrsN of conjugative transfer genes on staphylococcal plasmid pGO1.
J. Bacteriol.
176:3445-3454 |
| 34. |
Speer, B. S.,
N. B. Shoemaker, and A. A. Salyers.
1992.
Bacterial resistance to tetracycline: mechanisms, transfer, and clinical significance.
Clin. Microbiol. Rev.
5:387-399 |
| 35. |
Tesch, W.,
C. Ryffel,
A. Strässle,
F. H. Kayser, and B. Berger-Bächi.
1990.
Evidence of a novel staphylococcal mec-encoded element (mecR) controlling expression of penicillin-binding protein 2'.
Antimicrob. Agents Chemother.
34:1703-1706 |
| 36. | Thomas, W. D., and G. L. Archer. 1992. Mobilization of recombinant plasmids from Staphylococcus aureus into coagulase negative Staphylococcus species. Plasmid 27:164-168[CrossRef][Medline]. |
| 37. |
Ubukata, K.,
R. Nonoguchi,
M. Matsuhashi, and M. Konno.
1989.
Expression and inducibility in Staphylococcus aureus of the mecA gene, which encodes a methicillin-resistant S. aureus-specific penicillin-binding protein.
J. Bacteriol.
171:2882-2885 |
| 38. | Yanisch-Perron, C., J. Vieira, and J. Messing. 1985. Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mp18 and pUC19 vectors. Gene 33:103-119[CrossRef][Medline]. |
| 39. | York, M. K., L. Gibbs, F. Chehab, and G. F. Brooks. 1996. Comparison of PCR detection of mecA with standard susceptibility testing methods to determine methicillin resistance in coagulase-negative staphylococci. J. Clin. Microbiol. 34:249-253[Abstract]. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||